To investigate the prognostic factors of survival in patients with high-grade gliomas without isocitrate dehydrogenase-1 (IDH) mutation and O 6 -methylguanine-DNA methyltransferase (MGMT) methylation. Here, IDH1 is linked to central nervous system cancer.